Abstract
Magnetic nanoparticles have been proposed for biomedical applications for several years. Various research groups worldwide have focused on improving their synthesis, their characterization techniques and the specific tailoring of their properties. Yet, it is the recent, impressive advances in nanotechnology and biotechnology which caused the breakthrough in their successful application in biomedicine. This paper aims at reviewing some current biomedical applications of magnetic nanoparticles as well as some recent patents in this field. Special emphasis is placed on i) hyperthermia, ii) therapeutics iii) diagnostics. Future prospects are also discussed.
Keywords: Magnetic nanoparticles, biomedicine, drug delivery, hyperthermia, disease detection, therapy, cancer diagnostics, targeted therapeutics, magnetic imaging
Recent Patents on Nanotechnology
Title: Recent Progress in Biomedical Applications of Magnetic Nanoparticles
Volume: 4 Issue: 2
Author(s): Ioanna Giouroudi and Jurgen Kosel
Affiliation:
Keywords: Magnetic nanoparticles, biomedicine, drug delivery, hyperthermia, disease detection, therapy, cancer diagnostics, targeted therapeutics, magnetic imaging
Abstract: Magnetic nanoparticles have been proposed for biomedical applications for several years. Various research groups worldwide have focused on improving their synthesis, their characterization techniques and the specific tailoring of their properties. Yet, it is the recent, impressive advances in nanotechnology and biotechnology which caused the breakthrough in their successful application in biomedicine. This paper aims at reviewing some current biomedical applications of magnetic nanoparticles as well as some recent patents in this field. Special emphasis is placed on i) hyperthermia, ii) therapeutics iii) diagnostics. Future prospects are also discussed.
Export Options
About this article
Cite this article as:
Giouroudi Ioanna and Kosel Jurgen, Recent Progress in Biomedical Applications of Magnetic Nanoparticles, Recent Patents on Nanotechnology 2010; 4(2) . https://dx.doi.org/10.2174/187221010791208795
DOI https://dx.doi.org/10.2174/187221010791208795 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Role of Nanomedicines in Delivery of Anti-Acetylcholinesterase Compounds to the Brain in Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Trichostatin A - like Hydroxamate Histone Deacetylase Inhibitors as Therapeutic Agents: Toxicological Point of View
Current Medicinal Chemistry Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Small Molecules Targeting Mutant P53: A Promising Approach for Cancer Treatment
Current Medicinal Chemistry Drug Delivery Systems for Imaging and Therapy of Parkinson's Disease
Current Neuropharmacology Factors Affecting the Metabolite Productions in Endophytes: Biotechnological Approaches for Production of Metabolites
Current Medicinal Chemistry Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators
Anti-Cancer Agents in Medicinal Chemistry Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy
Current Drug Targets Quinazolines as Apoptosis Inducers and Inhibitors: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Mitochondrial Physiology and Toxicity (Mitotoxicity); Importance for the Immune System, Programmed Cell Death and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Fluorine-18 Labeled Amino Acids for Oncologic Imaging with Positron Emission Tomography
Current Topics in Medicinal Chemistry Cannabis sativa L. Constituents and Their Role in Neuroinflammation
Current Bioactive Compounds Editorial (Thematic Issue: GPCR-Targeted Drug Development)
Current Drug Targets Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy
Current Drug Delivery Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection
Current Molecular Pharmacology Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging
Current Medicinal Chemistry Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation
Anti-Cancer Agents in Medicinal Chemistry Elucidation of Abnormal Extracellular Regulated Kinase (ERK) Signaling and Associations with Syndromic and Non-syndromic Autism
Current Drug Targets Enzyme-responsive Nanoparticles for Anticancer Drug Delivery
Current Nanoscience